207-571-7 | Sigma-Aldrich

. Ed. Engl. 1998, 37, 2481. (7) Shulman, A. et al., submitted for publication in J. Chem. Ed. N O H OH O N O H H O O

158 AvaII 7 1666 2042 2130 2221 2500 4246 4468 BamHI 1 198 BanI 9 436 457 571 1034 1753 1883 2009 4056 5288 BanII 5 190 498 512 1325 5326 BbsI 4 1260 1599 1973 2333 BbvI 31 BccI 14 Bce83I 7 21 1928

TB071VM pET-26b(+) Vector Map

4556 4647 ThaI 35 TseI 28 Tsp45I 7 1295 2123 2654 2867 2962 4564 5291 Tsp509I 22 Tth111I 1 2960 Tth111II 8 953 1646 2676 3805 3812 3844 4253 4380 UbaJI 18 VspI 6 207 375 1799 1858 4616 4805 XbaI

Pathways and Biomarkers of Oxidative Stress

conjugate 16-226 Anti-Nitrotyrosine, clone 1A6, HRP conjugate 16-207 Anti-Nitrotyrosine Magnetic Bead Conjugate 16-310 Anti-nNOS/NOS I 07-571 Anti-Peroxiredoxin 1 07-609 Anti-Peroxiredoxin 2 07-610 Anti-Peroxiredoxin

TB044VM pET-14b Vector Map

14b sequence landmarks T7 promoter 646-662 T7 transcription start 645 His•Tag coding sequence 554-571 Multiple cloning sites (Nde I -BamH I) 510-526 T7 terminator 404-450 pBR322 origin 2845 bla coding

XP725 Antibody Number-Lot Number 071M4826

519 520 541 542 543 544 565 566 567 568 6.5 497 498 499 500 521 522 523 524 545 546 547 548 569 570 571 572 6.6 501 502 503 504 525 526 527 528 549 550 551 552 573 574

TB330VM pET-44a-c(+) Vector Map

coding sequence 747–791 Multiple cloning sites (Sma I-Xho I) 530–724 HSV•Tag® coding sequence 536–571 His•Tag® coding sequence 512–529 T7 terminator 26–73 lacI coding sequence 2833–3915 pBR322 origin 5109

Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma

IPI00418422 IGHD protein 79 1 47 1 IPI00448938 IGHG1 410 7 89 2 463 8 349 6 513 8 736 9 IPI00472345 IGHG3 protein 83 1 163 3 207 4 212 5 133 3 259 4 206 3

White Paper- Modern Methods in Oxidative Stress Research

Anti-Nitrotyrosine, clone 1A6, HRP conjugate 16-207 Anti-Nitrotyrosine, clone 2A8.2 MAB5404 Anti-nNOS/NOS I 07-571 Anti-nNOS/NOS I 07-571-I Anti-nNOS/NOS I, clone 2G1.1 MABN533 Anti-NOX4

XP725 Antibody List Lot 129K4831

P2482 207 AKT1 M NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 575 Protein Kinase Ba /Akt1 P1601 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 577 phospho-PKB (pSer473) P4112 207 AKT1

XP725 Antibody List Lot 129K4830

P2482 207 AKT1 M NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 575 Protein Kinase Ba /Akt1 P1601 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 577 phospho-PKB (pSer473) P4112 207 AKT1

XP725 Antibody List Lot 089K4791

P2482 207 AKT1 M NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 575 Protein Kinase Ba /Akt1 P1601 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 577 phospho-PKB (pSer473) P4112 207 AKT1

XP725 Antibody List

205 Cytokeratin peptide 7 C6417 3855 KRT7 NP_005547.3 M y n/d n/d 206 Cytokeratin 8.12 C7034 3866, 3860, 3868 KRT15,KRT16,KRT13 NP_002266.2,NP_705694.2,NP_005548.2 M y n/d n/d 207 Cytokeratin 8.13 C6909

XP725 Antibody List 013M4793

205 Cytokeratin peptide 7 C6417 3855 KRT7 NP_005547.3 M y n/d n/d 206 Cytokeratin 8.12 C7034 3866, 3860, 3868 KRT15,KRT16,KRT13 NP_002266.2,NP_705694.2,NP_005548.2 M y n/d n/d 207 Cytokeratin 8.13 C6909

List of Antibodies

n/d n/d 204 Cytokeratin CK5 C7785 M y n/d n/d 205 Cytokeratin peptide 7 C6417 M y n/d n/d 206 Cytokeratin 8.12 C7034 M y n/d n/d 207 Cytokeratin 8.13 C6909 M y n/d n/d 208 Cytokeratin peptide 13 C0791 M

XP725 Worksheet for Lot Number 071M4826

4 5 7 FOXP2 F6304 568 3 4 5 8 FOXP2 F6304 FANCD2 F0305569 3 4 6 1 570 3 4 6 2 FANCD2 F0305 571 3 4 6 3 FXR2 F1554 572 3 4 6 4 FXR2 F1554 573 3 4 6 5

3D BIOPRINTING: Printing a Brighter Future

M. Drug Res. 2020, 70, 6–11. (178) Tiwari, S.; Bahadur, P. Int. J. Biol. Macromol. 2019, 121, 556–571. (179) López-Marcial, G. R.; Zeng, A. Y.; Osuna, C.; Dennis, J.; García, J. M.; O’Connell, G. D

3D BIOPRINTING: Printing a Brighter Future

M. Drug Res. 2020, 70, 6–11. (178) Tiwari, S.; Bahadur, P. Int. J. Biol. Macromol. 2019, 121, 556–571. (179) López-Marcial, G. R.; Zeng, A. Y.; Osuna, C.; Dennis, J.; García, J. M.; O’Connell, G. D

Acta Interactive Archive Vol 51

67) Karad, S. N.; Pal, M.; Crowley, R. S.; Prisinzano, T. E.; Altman, R. A. ChemMedChem 2017, 12, 571. (68) Sato, K.; Tamura, M.; Tamoto, K.; Omote, M.; Ando, A.; Kumadaki, I. Chem. Pharm. Bull. 2000

Halal Certificate

ETHYL 2-METHYLBUTYRATE NATURAL, MIXTURE OF ENANTIOMERS, 98%, FCC, FG W244317 B80172 HC-24SI8Q26 571. ETHYL 2-TRANS-4-CIS-DECADIENOATE 80% W314803 B55781 HC-24SIPY55 This is to certify that the following

Halal Certificate

ETHYL 2-METHYLBUTYRATE NATURAL, MIXTURE OF ENANTIOMERS, 98%, FCC, FG W244317 B80172 HC-22SI7B24 571. ETHYL 2-TRANS-4-CIS-DECADIENOATE 80% W314803 B55781 HC-22SIHI53 This is to certify that the following